Galderma Group AG (GDERF)

OTCMKTS · Delayed Price · Currency is USD
120.50
0.00 (0.00%)
May 21, 2025, 4:00 PM EDT
55.04%
Market Cap 29.43B
Revenue (ttm) 4.44B
Net Income (ttm) 231.00M
Shares Out n/a
EPS (ttm) 0.97
PE Ratio 127.41
Forward PE 41.78
Dividend 0.18 (0.15%)
Ex-Dividend Date Apr 25, 2025
Volume n/a
Average Volume 1,442
Open 120.50
Previous Close 120.50
Day's Range 120.50 - 120.50
52-Week Range 77.72 - 120.50
Beta n/a
RSI 75.23
Earnings Date Jul 24, 2025

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic ... [Read more]

Sector Healthcare
Founded 1981
Employees 6,545
Stock Exchange OTCMKTS
Ticker Symbol GDERF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.